Validation of the Russian Version of Coma Recovery Scale-Revised (CRS-R)

Status Completed

Clinical Trial Summary

The purpose of this study is to validate Russian version of Coma Recovery Scale - Revised and to assess its psychometric properties.

Clinical Trial Description

There is a need of validated scale for correct assessment for patients with disorders of consciousness (DOC) in Russia. One of the most detailed scales that provides robust results in these patients is the Coma Recovery Scale - Revised (CRS-r). The validated Russian version of CRS-r will be very helpful in clinical work and scientific research for making correct assessment of patients status and its changes over time in Russia and Russian-speaking countries.

The purpose of this study is to validate Russian version of CRS-R and to assess its psychometric properties.

The first step of the study was to perform translation of CRS-r from English into Russian according to the validation protocol:

1. Double direct translation by independent translators;

2. Combination of two Russian translations;

3. Reverse translation by native English speaker.

Final Russian version and back-translated version of the Scale were approved by the original author, Dr. J. Giacino. He approved the original validation study protocol as well.

To validate Russian version of CRS-r and to assess its psychometric properties the investigators will perform an observational study on 60 adults with disorders of consciousness of different etiology on different period of recovery after coma. It is planned to include patients with various states of consciousness (e.g., vegetative state, minimally conscious state "minus" and minimally conscious state "plus") in balanced proportions.

Every patient will be examined by two independent researchers on the same day. The patients will be examined twice with a week interval between examinations for evaluation of sensitivity of CRS-r. Test-retest reliability will be applied to investigate interrater reliability. This method will be applied as well to assess the consistency of patients' scores over time. The internal consistency of the test will be investigated by inter-rater method. For this item two researchers will conduct patient assessment with CRS-R on the same day with a small period of time between the examinations. Content validity of the test will be used for assessment of validity of CRS-R. It will be performed with expert evaluation of the content of CRS-R by the investigators. Сriterion validity will be examined by assessing the correlations of CRS-R with the scales of other questionnaires with proven high psychometric properties for consciousness disorders: the Glasgow Coma Scale and Full Outline of UnResponsiveness (FOUR) score. ;

Study Design

Related Conditions & MeSH terms

Consciousness Disorders

Clinical Trial Details

NCT number	NCT03060317
Study type	Observational
Source	Research Center of Neurology, Russia
Contact
Status	Completed
Phase	N/A
Start date	November 1, 2016
Completion date	July 12, 2017

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06443827` - Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness	Phase 2
Recruiting	`NCT02667899` - The Consciousness Variation of Deep Brain and Transcranial Magnetic Stimulation for Disorders of Consciousness Patients	N/A
Recruiting	`NCT06406413` - Micro-movements in Patients With Prolonged Disorders of Consciousness
Not yet recruiting	`NCT06389344` - Effect of Esketamine on Conscious State in Patients With pDoC	N/A
Terminated	`NCT02522429` - Thalamic Low Intensity Focused Ultrasound in Brain Injury	N/A
Completed	`NCT02772302` - Feasibility of mindBEAGLE in Disorders of Consciousness or Locked-In Syndrome	N/A
Recruiting	`NCT06088628` - Micro-expressions in Patients With Prolonged Disorders of Consciousness
Recruiting	`NCT02714491` - Effects of Auditory Stimulation During Verticalization With Erigo in Patients With Disorder of Consciousness	N/A
Terminated	`NCT03367078` - tDCS in Patients With Disorder of Consciousness Due to Severe Acquired Brain Injury
Completed	`NCT02828371` - Early Stepping Verticalization in ICU for ABI Patients	N/A
Recruiting	`NCT06426615` - Connectivity and Neural Signatures of Consciousness in Unresponsive States	N/A
Recruiting	`NCT06211439` - Transcranial Alternating Current Stimulation in Patients With Disorders of Consciousness	N/A
Not yet recruiting	`NCT02659228` - Assessing Covert Consciousness in Unresponsive Patients	N/A
Completed	`NCT00700869` - Evaluation of a New Mechanical Ventilation Weaning Strategy for Patients With Altered Level of Consciousness	Phase 2/Phase 3
Recruiting	`NCT02644265` - CONNECT-ME: Consciousness in Neurocritical Care Cohort Study Using fMRI and EEG
Completed	`NCT01141790` - Analysis of Vital, Facial and Muscular Responses Front to Music or Message in Coma, Vegetative State or Sedated Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.